The most transformative software companies are those that have seized the opportunity to incorporate clinician and patient voices into the design of their health IT tools, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.
The most transformative software companies are those that have seized the opportunity to incorporate clinician and patient voices into the design of their health information technology (IT) tools, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.
Transcript (slightly modified)
What are some oncology challenges that can be turned into opportunities with health IT?
Well, it’s interesting, coming off this panel one of the big things that we talked about is workflow. That so much of what health IT is available to clinicians and care teams right now has not been designed with attention to workflow at the point of care. And all the panel members today in the “Surmounting IT Challenges” section of the conference today highlighted, myself included, what an opportunity that is.
Suzanne [Belinson] with BlueCross, I think stated it very well [at the Patient-Centered Oncology Care meeting]. She said now it is the companies who have either clinicians at their leadership level and/or who are dedicated to bringing clinicians and care teams in the process of designing software that are really being disruptive in the most positive sense of that term, transforming how health IT supports providers, care teams, and patients and families by bringing their voices into the development and ensuring that they’re a part of the solution of designing and testing and improving these health IT solutions. That’s the crux of it.
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More